Radiology - Global Oncology Academy

Episodes 1-6 of 6

- Kevin J. Harrington, MBBS, PhD
  Peer
- Barbara Burtness, MD
  Peer
- Ari Rosenberg, MD
  Peer
3
CME/CE
Innovations in the Treatment of Locally Advanced Squamous Cell Carcinoma of Head and Neck: Enhancing Antitumor Activity Through Inhibitor of Apoptosis Protein Antagonism
Innovations in the Treatment of Locally Advanced Squamous Cell Carcinoma of Head and Neck: Enhancing Antitumor Activity Through Inhibitor of Apoptosis Protein Antagonism
0.25 credits
Innovations in the Treatment of Locally Advanced Squamous Cell Carcinoma of Hea…
0.25 credits
- Nichole Tanner, MD, MS, FCCP
  Peer
- Eric Edell, MD, FCCP
  Peer
- Septimiu Murgu, MD, FCCP
  Peer
0
CME/CE
Lung Cancer Screening & What to Do When a Nodule Is Detected
Lung Cancer Screening & What to Do When a Nodule Is Detected
0.25 credits
Lung Cancer Screening & What to Do When a Nodule Is Detected
0.25 credits
- Janani Reisenauer, MD
  Peer
- Septimiu Murgu, MD, FCCP
  Peer
- Eric Edell, MD, FCCP
  Peer
0
CME/CE
Management Tools for Early-Stage Lung Cancer
Management Tools for Early-Stage Lung Cancer
0.25 credits
Management Tools for Early-Stage Lung Cancer
0.25 credits
- Jacob Sands, MD
  Peer
- Aaron S. Mansfield, MD
  Peer
4
Project Oncology®
Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?
Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?
Exploring Early-Stage Mesothelioma: What Are the Latest Treatment Approaches?
- Jacob Sands, MD
  Peer
- Aaron S. Mansfield, MD
  Peer
3
Project Oncology®
A Step-by-Step Approach to Managing Mesothelioma
A Step-by-Step Approach to Managing Mesothelioma
A Step-by-Step Approach to Managing Mesothelioma
- Shira Johnson, MD
  Peer
- Ronald DeMatteo, MD, FACS
  Peer
17
Medical Breakthroughs from Penn Medicine
What to Know About a State-of-the-Art Approach to GIST Treatment
What to Know About a State-of-the-Art Approach to GIST Treatment
What to Know About a State-of-the-Art Approach to GIST Treatment

Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers

Elizabeth Smyth, MD

Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers

Learn More

Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers

UP NEXT...

Adjuvant Nivolumab Alone or in Combination with Ipilimumab Versus Placebo in Stage IV Melanoma with No Evidence of Disease: Overall Survival Results of IMMUNED, a Randomized, Double-Blind Multi-Center Phase 2p DeCOG Trial

CME

Guest
Dirk Schadendorf, MD